Check the box if any part of the fee is offset as provided by Rule 0-11(a)(2) and identify the filing with which the offsetting fee was previously paid. Identify the previous filing by registration statement number, or the Form of Schedule and the date of its filing.

Check the box if the filing relates solely to preliminary communications made before commencement of a tender offer.

third-party tender offer subject to Rule 14d-1.

issuer tender offer subject to Rule 13e-4.

going-private transaction subject to Rule 13e-3.

amendment to Schedule 13D under Rule 13d-2.

Summary Term Sheet.

Subject Company Information.

The name of the issuer is First Eagle Private Credit Fund (the “Fund”). The Fund is a non-diversified, closed-end management investment company that has elected to be regulated as a business development company under the Investment Company Act of 1940, as amended (the “1940 Act”). It is organized as a Delaware statutory trust. The principal executive office of the Fund is located at 1345 Avenue of the Americas, New York, New York 10105 and the telephone number is (212) 698-3300.

The title of the securities that are the subject of the offer to purchase and the related Letter of Transmittal (“Offer to Purchase” and the tender offer made thereby, the “Offer”) are Class I common shares of beneficial interest (the “Class I Shares”) and Class D common shares of beneficial interest (the “Class D Shares” and together with Class I Shares, the “Shares”) or portions thereof. As of the close of business on June 30, 2025, there were 12,446,559 Shares outstanding. Subject to the conditions set forth in the Offer to Purchase, the Fund will purchase up to 622,328 Shares that are tendered by holders of the Fund’s Shares (“Shareholders”) and not withdrawn as described in the Offer to Purchase (the “Offer Amount”). The Shares subject to the Offer represent approximately 5% of the Fund’s Shares outstanding as of June 30, 2025.

Shares are not traded in any market.

Identity and Background of Filing Person.

The Fund is tendering for its own Shares. The information required by this Item is set forth in Item 2(a) above. First Eagle Investment Management, LLC (the “Adviser”) oversees the management of the Fund’s activities and supervises the activities of First Eagle Alternative Credit, LLC (the “Subadviser”, and together with the Adviser, the “Advisers”). The Adviser is located at 1345 Avenue of the Americas, New York, NY 10105. and its telephone number is (212) 698-3300. The Subadviser is located at 500 Boylston Street, Suite 1250, Boston, MA 02116 and its telephone number is (212) 829-3101.The members of the Fund’s Board of Trustees (the “Board”) are Nancy Hawthorne, Rajender Chandhok, Patrick Coyne, Stuart George, Laurence Smith and David O’Connor (each, a “Trustee”). The President and Chief Executive Officer is David O’Connor, the Chief Financial Officer and Treasurer is Jennifer Wilson, the Deputy General Counsel and Assistant Secretary is Smriti Kodandapani, the Deputy General Counsel is William Karim, the Deputy General Counsel is Sheelyn Michael, the Interim Chief Compliance Officer is Seth Gelman, the Vice President is Michael Luzzatto, the Assistant Secretary is Casey Walker. The Trustees and the executive officers of the Fund may be reached at the Fund’s business address and phone number set forth in Item 2(a) above.

Not applicable.

Terms of the Transaction.

Subject to the conditions set forth in the Offer to Purchase, the Fund will purchase up to 622,328 Shares that are tendered by Shareholders by 11:59 p.m., Eastern Time, on August 29, 2025 and not withdrawn as described in Item 4(a)(1)(vi).

The purchase price of a Share (or portion thereof) tendered will be its net asset value as of September 30, 2025 or a later date determined by the Fund if the Offer is extended (in each case, the “Valuation Date”), upon the terms and subject to the conditions set forth in the Offer to Purchase. Reference is made to the Cover Page, Section 2 “Offer to Purchase and Price” and Section 6 “Purchases and Payment” of the Offer to Purchase, which are incorporated herein by reference.

The Offer is scheduled to expire on August 29, 2025 unless extended. Reference is made to the Cover Page, Summary Term Sheet, Section 2 “Offer to Purchase and Price” and Section 5 “Withdrawal Rights” of the Offer to Purchase, which are incorporated herein by reference.

Not applicable.

Reference is made to the Cover Page, Summary Term Sheet and Section 7 “Certain Conditions of the Offer” of the Offer to Purchase, which are incorporated herein by reference.

Reference is made to Section 5 “Withdrawal Rights” of the Offer to Purchase, which is incorporated herein by reference.

Reference is made to the Cover Page, Section 4 “Procedure for Tenders” and Section 5 “Withdrawal Rights” of the Offer to Purchase, which are incorporated herein by reference. Note that certain Shareholders may be required to deliver their Letter of Transmittal to their Financial Advisor (instead of directly to SS&C GIDS, Inc.). All Shareholders tendering Shares should carefully review their Letter of Transmittal and follow the delivery instructions therein.

Reference is made to Section 4 “Procedure for Tenders” and Section 6 “Purchases and Payment” of the Offer to Purchase, which are incorporated herein by reference.

Reference is made to the Cover Page, Section 3 “Amount of Tender,” and Section 6 “Purchases and Payment” of the Offer to Purchase, which are incorporated herein by reference.

Reference is made to Section 2 “Offer to Purchase and Price,” which is incorporated herein by reference.

Not applicable.

Reference is made to Section 10 “Certain Federal Income Tax Consequences” of the Offer to Purchase, which is incorporated herein by reference.

Any Shares to be purchased from any officer, Trustee or affiliate of the Fund will be on the same terms and conditions as any other purchase of Shares. To the Fund’s knowledge, none of the officers, Trustees, or affiliates of the Fund intends to tender Shares in the Offer.

Past Contracts, Transactions, Negotiations and Agreements with Respect to the Issuer’s Securities.

The Fund’s prospectus dated April 30, 2025, as amended and/or supplemented from time to time (the “Prospectus”), provides that the Board has the discretion to determine whether the Fund will purchase Shares from Shareholders from time to time pursuant to written tenders. The Advisers expect that they will recommend to the Board that the Fund purchase Shares from Shareholders quarterly. However, the Fund is not required to conduct tender offers. The Fund does not know of any other contract, agreement, arrangement, or understanding, whether contingent or otherwise or whether or not legally enforceable, between the (i) Fund, any of the Fund’s executive officers or Trustees, any person controlling the Fund, or any executive officer or director of any corporation ultimately in control of the Fund and (ii) any other person with respect to any securities of the Fund (including any contract, agreement, arrangement, or understanding concerning the transfer or the voting of any such securities, joint ventures, loan or option arrangements, puts or calls, guarantees of loans, guarantees against loss, or the giving or withholding of proxies, consents or authorizations).

Purposes Of This Tender Offer and Plans Or Proposals.

Reference is made to Section 1 “Background and Purpose of the Offer” of the Offer to Purchase, which is

incorporated herein by reference.

Reference is made to Section 8 “Certain Information About the Fund” of the Offer to Purchase, which is incorporated herein by reference. Because Shares are not traded in any market, subsections (6), (7), and (8) of Regulation M-A Item 1006(c) are not applicable to the Fund.

Source and Amount of Funds or Other Consideration.

Reference is made to Section 6 “Purchases and Payment” of the Offer to Purchase, which is incorporated

herein by reference.

Not applicable.

None of the Fund, the Advisers or the Board or any person controlling the Fund, the Advisers or the Board has determined at this time to borrow funds to purchase Shares tendered in connection with the Offer. Depending on the dollar amount of Shares tendered and prevailing general economic and market conditions, the Fund, in its sole discretion, may decide to seek to borrow money to fund all or a portion of the purchase amount for Shares, subject to compliance with applicable law. The Fund expects that the repayment of any amounts borrowed will be financed from additional funds contributed to the Fund by existing or new Shareholders.

Interest in Securities of the Issuer.

Based on the number of Shares outstanding as of June 30, 2025, the following persons own the number of Shares indicated in the below table.

Adviser

Subadviser

David O’Connor

Nancy Hawthorne

Rajender Chandhok

Patrick Coyne

Stuart George

Laurence Smith

Jennifer Wilson

Smriti Kodandapani

William Karim

Sheelyn Michael

Seth Gelman

Michael Luzzatto

Casey Walker

Based on Shares owned by FEPCF Founders Fund, L.P. (“Founders Fund”). FEPCF Founders Fund GP LLC (“Founders Fund GP”) is the sole general partner of Founders Fund. FEAC is the investment advisor to Founders Fund and sole member of Founders Fund GP. FEIM is the sole and managing member of FEAC. First Eagle Holdings, Inc. (“FEH”) is the managing member of FEIM. Founders Fund, Founders Fund GP, FEAC, FEIM and FEH maintain the shared power to vote or dispose of 8,306,421 Shares consisting of 4,566 Shares held directly by FEIM and 8,301,855 Shares directly held by Founders Fund.

Reference is made to Section 8 “Certain Information About the Fund” of the Offer to Purchase, which is incorporated herein by reference. During the past sixty (60) days, the Fund has issued to the Advisers, Trustees and officers of the Fund an aggregate of approximately 77 Shares, including the net impact of Shares issued pursuant to the Fund’s dividend reinvestment plan, for net proceeds of approximately $0.0 million to the Advisers, any Trustee or officer of the Fund, or any person controlling the Fund or the Advisers. There have been no other transactions in Shares effected during the past sixty (60) days by the Fund, the Advisers, or any Trustee or executive officer of the Fund, or any person controlling the Fund or the Advisers.

Persons/Assets Retained, Employed, Compensated or Used.

No persons have been employed, retained, or are to be compensated by the Fund to make solicitations or recommendations in connection with the Offer to Purchase.

Financial Statements.

The audited annual financial statements of the Fund dated December 31, 2024 filed with the SEC on EDGAR on March 14, 2025 are incorporated by reference. The Fund will prepare and transmit to Shareholders the audited annual financial statements of the Fund within 90 days after the close of the period for which the report is being made, or as otherwise required by the 1940 Act.

Not applicable.

Additional Information.

(1) None.

None.

Not applicable.

None.

None.

The Offer to Purchase, attached hereto as Exhibit (a)(1)(ii), is incorporated herein by reference in its entirety.

Exhibits.

Cover Letter to Offer to Purchase and Letter of Transmittal.

Offer to Purchase.

Forms of Letter of Transmittal.

Form of Letter from the Fund to Shareholders in Connection with the Fund’s Acceptance of Shares.

Form of Promissory Note.

Forms of Notice of Withdrawal of Tender.

None.

Not applicable.

Not applicable.

Not applicable.

Filing Fee Table

/s/ Jennifer Wilson